摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

<(2E,4E)-5-<(R)-4-hydroxy-2,6,6-trimethylcyclohex-1-enyl>-3-methylpenta-2,4-dienyl>triphenylphosphonium chloride | 76686-31-2

中文名称
——
中文别名
——
英文名称
<(2E,4E)-5-<(R)-4-hydroxy-2,6,6-trimethylcyclohex-1-enyl>-3-methylpenta-2,4-dienyl>triphenylphosphonium chloride
英文别名
(R)-((2E,4E)-5-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3-methylpenta-2,4-dien-1-yl)triphenylphosphonium chloride;zeanyl phosphonium chloride;[(2E,4E)-(R)-5-(4-hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl)-3-methyl-2,4-pentadienyl]-triphenylphosphonium chloride;[(2E,4E)-5-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-3-methylpenta-2,4-dienyl]-triphenylphosphanium;chloride
<(2E,4E)-5-<(R)-4-hydroxy-2,6,6-trimethylcyclohex-1-enyl>-3-methylpenta-2,4-dienyl>triphenylphosphonium chloride化学式
CAS
76686-31-2
化学式
C33H38OP*Cl
mdl
——
分子量
517.091
InChiKey
CLSHILBUUPPOFW-XHDHOVAISA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.98
  • 重原子数:
    36
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:01e35b17fcd931843ebb6890d5ed5558
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Total Synthesis of (3<i>R</i>,3′<i>R</i>,6′<i>R</i>)-Lutein and Its Stereoisomers
    作者:Frederick Khachik、An-Ni Chang
    DOI:10.1021/jo900432r
    日期:2009.5.15
    prevention of age-related macular degeneration (AMD). While the total synthesis of 1 has been previously reported in a poor overall yield, the total synthesis of the other seven stereoisomers of lutein has not yet been accomplished. We have developed a relatively straightforward methodology for the total synthesis of 1 and three of its stereoisomers, (3R,3′S,6′S)-lutein (2), (3R,3′S,6′R)-lutein or 3′-epilutein
    (3 - [R,3' - [R,6' - [R)-Lutein(1)是主要的膳食类胡萝卜素是一种大多数水果和蔬菜在美国普遍食用,而且人血浆,主要器官和眼组织中积累了丰富的。大量的流行病学和实验研究表明1具有重要的生物学活性,并且在预防老年性黄斑变性(AMD)中可能起重要作用。虽然以前已经报道了1的总合成,但是总收率却很低,但叶黄素其他7种立体异构体的总合成尚未完成。我们已经开发出一种相对简单的方法来进行1的全合成和三个其立体异构体,(3 - [R,3'小号,6'小号)-lutein(2),(3 - [R,3'小号,6' - [R)-lutein或3'-表叶黄素(3),和(3 [R,3' - [R,6'小号)-lutein(4由C)15 + C 10个+ C 15维悌希偶联反应。利用这种方法,可以类似地制备与上述叶黄素异构体对映异构的叶黄素的其他四种立体异构体。该策略的重要特征之一是其在13
  • Separation and identification of carotenoids and their oxidation products in the extracts of human plasma
    作者:Frederick Khachik、Gary R. Beecher、Mudlagiri B. Goli、William R. Lusby、James C. Smith
    DOI:10.1021/ac00042a016
    日期:1992.9.15
    Eighteen carotenoids as well as vitamin A and two forms of vitamin E (gamma- and alpha-tocopherol) have been separated from extracts of human plasma by high-performance liquid chromatography (HPLC) on reversed-phase and sillca-based nitrile-bonded columns. In the order of chromatographic elution on a C18 reversed-phase column, the carotenoids were identified as (3R,3'R,6'R)-beta, epsilon-carotene-3
    在反相和基于Sillca的腈键色谱柱上,通过高效液相色谱(HPLC)从人血浆提取物中分离出了十八种类胡萝卜素以及维生素A和两种形式的维生素E(γ-和α-生育酚) 。按照在C18反相色谱柱上的色谱洗脱顺序,类胡萝卜素被鉴定为(3R,3'R,6'R)-β,ε-胡萝卜素-3,3'-二醇[(3R,3'R ,6'R)-叶黄素],(3R,3'R)-β,β-胡萝卜素-3,3'-二醇[(3R,3'R)-玉米黄质],5,6-二羟基-5,6 -dihydro-psi,psi-胡萝卜素,3-羟基-2',3'-二氢-β,ε-胡萝卜素-3-醇,3-羟基-β-胡萝卜素,psi,psi-胡萝卜素,7,8-二氢-psi,psi-胡萝卜素,beta,psi-胡萝卜素,7,8,7',8'-四氢psi,psi-胡萝卜素,beta,ε-胡萝卜素,beta,beta-胡萝卜素,7,8,11,12 ,7',8'-hexahydro-psi,psi-胡萝卜素和7
  • Synthesis of 13C-labelled (all-E,3R,3′R)-β,β-carotene-3,3′-diol (zeaxanthin) at C(12), C(13), C(12′), and C(13′) via all-E-2,7-dimethylocta-2,4,6-triene-1,8-dial-13C4
    作者:Frederick Khachik、Gary R. Beecher、Betty W. Li、Gerhard Englert
    DOI:10.1002/jlcr.2580361206
    日期:1995.12
    The title compound (10) has been synthesized from all-E-2,7- dimethylocta-2,4,6-triene-1,8-dial (C10-dialdehyde, 8) labelled with four 13C from commercially available and relatively inexpensive starting materials. The key starting material in this synthesis, (EtO)2P(O)13CHMe13CO2Et (2), has been prepared from triethyl phosphonoacetate-13C2. The sodium salt of 2 reacted with fumarylaldehyde dimethylacetal to give ethyl 6,6-dimethoxy-2-methyl-E, E-2,4-hexadienoate (4) which was converted to 8 in four steps [(1) acid hydrolysis, (2) 2/NaH, (3) LiAlH4 reduction, (4) MnO2 oxidation]. The overall yield of 8 based on phosphonate 1 is 43-46%. The double Wittig reaction of 8 with [(3R-3-hydroxy-β-ionylidene)ethyl]triphenylphosphonium chloride afforded 10 also known as (all-E,3R,3′R)-zeaxanthin-13C4 (39% based on phosphonate 1) in high purity. This synthetic method may be extended to prepare other 13C-labelled carotenoids.
    标题化合物 (10) 是由全-E-2,7-二甲基辛-2,4,6-三烯-1,8-二(C10-二醛,8)标记了 4 个 13C 的全-E-2,7-二甲基辛-2,4,6-三烯-1,8-二(C10-二醛,8)从市面上相对便宜的起始材料合成的。本合成中的关键起始材料 (EtO)2P(O)13CHMe13CO2Et (2) 是由磷酰乙酸三乙酯-13C2 制备的。2 的钠盐与富马酸醛二甲基乙缩醛反应生成 6,6-二甲氧基-2-甲基-E,E-2,4-己二烯酸乙酯 (4),该乙酯通过四个步骤转化为 8 [(1)酸水解,(2)2/NaH,(3)LiAlH4 还原,(4)MnO2 氧化]。基于膦酸盐 1 的 8 的总产率为 43-46%。将 8 与[(3R-3-羟基-β-亚氮基)乙基]三苯基氯化鏻进行双威蒂希反应,可得到高纯度的 10,也称为 (all-E,3R,3′R)-玉米黄质-13C4(39%,基于膦酸盐 1)。这种合成方法可扩展用于制备其他 13C 标记的类胡萝卜素。
  • Synthesis, Isolation, and Full Spectroscopic Characterization of Eleven (Z)-Isomers of (3R,3?R)-Zeaxanthin
    作者:Gerhard Englert、Klaus Noack、Emil A. Broger、Ernst Glinz、Max Vecchi、Reinhard Zell
    DOI:10.1002/hlca.19910740507
    日期:1991.8.7
    Developmental efforts to improve the yield of the chemical synthesis of (3R,3′R)-zeaxanthin resulted in the isolation, partly by chromatography from reaction mixtures, and full spectroscopic characterization by 1H-NMR, UV/VIS, and CD spectrosocpy of eleven (Z/E)-isomers of zeaxanthin: (7Z)-, (9Z), (13Z)-, (15Z)-, (7Z,7′Z)-, (9Z,9′Z)- (7Z,9Z,7Z)-, (7Z,11Z,7′Z)-, (9Z,13Z,9′Z)-, (7Z,9Z,7′Z,9′Z)-, and
    发展努力来改善(3的化学合成的产率[R,3' - [R)-zeaxanthin导致隔离,部分地被从反应混合物中层析,并通过全光谱表征1 H-NMR,UV / VIS,和CD spectrosocpy玉米黄质的11种(Z / E)异构体的组成:(7 Z)-,(9 Z),(13 Z)-,(15 Z)-,(7 Z,7'Z)-,(9 Z,9 ′ Z)-(7 Z,9 Z,7 Z)-,(7 Z,11 Z,7′Z)-,(9 Z,13 Z,9'Z)-,(7 Z,9 Z,7'Z,9'Z)-和(7 Z,9 Z,11 Z,7'Z,9' Z)-玉米黄质。这些异构体中的五个是通过特定合成获得的,即(7 Z)-,(7 Z,7'Z)-,(9 Z,9'Z)-,(7 Z,9 Z,7'Z)-和(7 ž,9 ž,7' ž -9 ž) -异构体。
  • Retinoids
    申请人:Hoffman-La Roche Inc.
    公开号:US05990329A1
    公开(公告)日:1999-11-23
    Compounds of the formula: ##STR1## wherein R.sup.2 and X are as described, are disclosed. The compounds are useful for treating dermatological disorders which are accompanied by epithelial lesions, e.g., acne and psoriasis, as well as malignant and premalignant epithelial lesions, tumours and precancerous changes of the mucous membrane in the mouth, tongue, larynx, oesophagus, bladder, cervix and colon.
    公式为##STR1##的化合物被揭示,其中R.sup.2和X的描述如上。这些化合物可用于治疗伴有上皮病变的皮肤病,例如痤疮和银屑病,以及恶性和前恶性上皮病变、肿瘤和口腔、舌、喉、食管、膀胱、子宫颈和结肠粘膜的癌前病变。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐